Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients.

Lee, Seung Ah; Hwang, Seung Hyun; Ahn, Sung Gwe; Lee, Hak Min; Jeong, Joon; Lee, Hy-De

Lee, Seung Ah; Hwang, Seung Hyun; Ahn, Sung Gwe; Lee, Hak Min; Jeong, Joon; Lee, Hy-De.

Affiliation

Lee SA; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 712, Eonjuro, Gangnam-Gu, Seoul 135-720, Korea.

Breast Cancer Res Treat ; 130(3): 863-70, 2011 Dec.

Article in En | MEDLINE | ID: mdl-21861101

Subject(s)

Aromatase Inhibitors/therapeutic use; Bone Density Conservation Agents/therapeutic use; Bone Density/drug effects; Breast Neoplasms/drug therapy; Diphosphonates/therapeutic use; Imidazoles/therapeutic use; Postmenopause; Adult; Aged; Aromatase Inhibitors/adverse effects; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Korea; Middle Aged; Osteoporosis/chemically induced; Osteoporosis/prevention & control; Zoledronic Acid

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Bone Density / Postmenopause / Aromatase Inhibitors / Diphosphonates / Bone Density Conservation Agents / Imidazoles Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Breast Cancer Res Treat Year: 2011 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google